Skip to content

Addiction: all studies

Page 495 of 855: studies 4,941 to 4,950 of 8,547, newest first. Back to the addiction overview

Research

An academic survey on theoretical foundations, common assumptions and the current state of the field of consciousness science

June 14, 2021 Jolien C. Francken, L. Beerendonk, D. Molenaar et al. 23 citations preprint

We report the results of an academic survey into the theoretical and methodological foundations, common assumptions and the current state of the field of consciousness science. The survey consisted of 22 questions, was distributed online and at two different occasions of the annual meeting of the Association of the Scientific Study of Consciousness (ASSC, 2018 and 2019), targeting active...

Ketamine for the multivariate effect of PTSD: Systematic review and meta-analysis

medRxiv Preprint Server June 13, 2021 Rui Du, Kun Niu, Guofang Lu et al. preprint

The aim of this systematic review and meta-analysis was to examine the efficacy, anti-effect of ketamine (intervention) for post-traumatic stress disorder (PTSD) patients during analgesia proceeding and mental illness treatment methods, in comparison with control (midazolam, opioid, saline or placebo). The bibliographic databases Cochrane, Embase, Pubmed and Web of Science were searched from...

The Phenomenology and Neurobiology of Visual Distortions and Hallucinations in Schizophrenia: An Update.

Frontiers in Psychiatry June 11, 2021 Steven M. Silverstein, Adriann Lai

Schizophrenia is characterized by visual distortions in ~60% of cases, and visual hallucinations (VH) in ~25-50% of cases, depending on the sample. These symptoms have received relatively little attention in the literature, perhaps due to the higher rate of auditory vs. visual hallucinations in psychotic disorders, which is the reverse of what is found in other neuropsychiatric conditions....

Psilocybin: A brief overview for psychiatric mental health nurse practitioners

Perspectives In Psychiatric Care June 8, 2021 Dina Fradkin 3 citations

The use of psychedelics, such as psilocybin, has emerged in recent literature as a novel therapeutic treatment for various psychiatric disorders, including substance use, depression, and anxiety. While international and domestic trials are currently underway, there is data demonstrating both the relative safety and potential efficacy of psilocybin. Psychiatric mental health nurse practitioners...

Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.

Experimental and Clinical Psychopharmacology June 7, 2021 Colleen Fogg, Timothy I. Michaels, Sara de la Salle et al. 53 citations

Emerging evidence from randomized, double-blind, placebo-controlled clinical trials suggests psychedelic compounds such as 3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and lysergic acid diethylamide (LSD), when administered as an adjunct to psychotherapy, that is, psychedelic-assisted psychotherapy (PAP), may be beneficial for treating substance use disorders, posttraumatic stress...

DOI: 10.1037/pha0000490 (opens in new tab) Psychotherapist Clinical psychology

Effects of a group mindfulness-based cognitive programme on smartphone addictive symptoms and resilience among adolescents: study protocol of a cluster-randomized controlled trial

BMC Nursing June 5, 2021 Anson Chui-Yan Tang, Regina Lee 38 citations

BACKGROUND: Smartphone addiction in adolescent is a significant global health issue since the last decade. Evidence has shown that the uncontrolled use of smartphone would lead to undesirable impact on their growth and development. However, evidence-based interventions to manage adolescents' smartphone addictive behaviors is lacking. The proposed study aims to examine the effect of a group...

Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives

The American Journal of Drug and Alcohol Abuse June 5, 2021 David J. Cox, Albert Garcia‐romeu, Matthew W. Johnson 29 citations

Background: Experiences with psychedelic drugs, such as psilocybin or lysergic acid diethylamide (LSD), are sometimes followed by changes in patterns of tobacco, opioid, and alcohol consumption. But, the specific characteristics of psychedelic experiences that lead to changes in drug consumption are unknown.Objective: Determine whether quantitative descriptions of psychedelic experiences...

DOI: 10.1080/00952990.2021.1910830 (opens in new tab) Cannabis Narrative Harm reduction Clinical psychology +1

Qualia, (Private) Language and Experience

СИНЕЗА June 3, 2021 Юлія Шабанова

The purpose of this paper is to analyze the relationship between qualia and language. Author will begin with the explanation of the nature of qualia using the negative method (second and third chapter), which will reveal that qualia are neither ontological properties in a traditional sense, viewed as instances of subjective experience, nor that they possess any epistemological value as such. In...

Dissociative and analgesic properties of ketamine are independent and unaltered by sevoflurane general anesthesia

PAIN Reports June 3, 2021 Eunice Y. Hahm, Shubham Chamadia, J. Locascio et al. 6 citations

Ketamine-induced dissociation and analgesia are independent and robust to general anesthesia neural circuit alterations, suggesting that ketamine can be refined into a targeted pain therapeutic. Abstract Introduction: Ketamine, an anesthetic adjunct, is routinely administered as part of a balanced general anesthetic technique. We recently showed that the acute analgesic and dissociation...

Corona XXXVII – speed of thought

Journal of Cell Science June 1, 2021

Tom Seaver: Hey Yogi, what time is it?Yogi Berra: You mean now?Everyone knows this: If you drop something yummy, like a chocolate fudge brownie, on the floor, the nasty floor microbes gather around it, hovering, for precisely three seconds before storming in. This is why you can pick it up and eat it if less than three seconds have elapsed. How the microbes know to wait precisely three seconds...